fulvestrant has been researched along with gamma-linolenic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colomer, R; Lupu, R; Menendez, JA | 1 |
1 other study(ies) available for fulvestrant and gamma-linolenic acid
| Article | Year |
|---|---|
Omega-6 polyunsaturated fatty acid gamma-linolenic acid (18:3n-6) is a selective estrogen-response modulator in human breast cancer cells: gamma-linolenic acid antagonizes estrogen receptor-dependent transcriptional activity, transcriptionally represses e
Topics: Breast Neoplasms; Drug Synergism; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; gamma-Linolenic Acid; Humans; Luciferases; Neoplasms, Hormone-Dependent; Promoter Regions, Genetic; Receptors, Estrogen; Tamoxifen; Transcription, Genetic; Tumor Cells, Cultured | 2004 |